Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

ARAY 11.26.2024

Full Press ReleaseSEC FilingsOur ARAY Tweets

About Gravity Analytica

Recent News

  • 02.05.2025 - Q2 2025 Accuray Incorporated Earnings Conference Call
  • 01.22.2025 - Accuray to Report Second Quarter Fiscal 2025 Financial Results on February 5, 2025
  • 01.21.2025 - Leonel Peralta to Join Accuray as Chief Operations Officer

Recent Filings

  • 01.21.2025 - 8-K Current report
  • 01.21.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 01.21.2025 - EX-99.1 EX-99.1

MADISON, Wis.,Nov. 26, 2024/PRNewswire/ --Accuray Incorporated(NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards toMike Murphy, the company's new Vice President, Corporate Controller. As a material inducement toMr. Murphyjoining the company, and in accordance with NASDAQ Listing Rule 5635(c)(4), the Compensation Committee approved grantingMr. Murphyan award of 150,000 restricted stock units covering shares of the company's common stock effective as ofNovember 29, 2024(collectively, the "Inducement Awards"). The Inducement Awards were made outside of the company's current equity plan, but are subject to terms and conditions generally consistent with those in the company's 2016 Equity Incentive Plan.

Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)

Twenty-five percent of the restricted stock units subject to the restricted stock unit award will vest on each yearly anniversary ofOctober 31, 2024, subject toMr. Murphy'scontinued service through each applicable vesting date.

AboutAccurayAccurayis committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster.Accurayis headquartered inSunnyvale, California, with facilities worldwide. To learn more, visitwww.accuray.comor follow us onFacebook,LinkedIn,X, andYouTube.

Media ContactBeth KaplanPublic Relations Director,Accuray+1 (408) 789-4426bkaplan@accuray.com

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-incorporated-reports-inducement-award-under-nasdaq-listing-rules-302316426.html

SOURCEAccuray Incorporated

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com